Molecular regulation of vascular smooth muscle cell differentiation in development and disease.
暂无分享,去创建一个
[1] T. Mayadas,et al. A new class of obesity genes encodes leukocyte adhesion receptors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[2] L. Kuo,et al. Dietary-induced atherosclerotic lesions have increased levels of acidic FGF mRNA and altered cytoskeletal and extracellular matrix mRNA expression. , 1993, Journal of vascular research.
[3] G. Owens,et al. Smooth Muscle &agr;-Actin Gene Requires Two E-Boxes for Proper Expression In Vivo and Is a Target of Class I Basic Helix-Loop-Helix Proteins , 2003, Circulation research.
[4] V. Koteliansky,et al. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth. , 1999, Circulation research.
[5] S. Tapscott,et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Greenberg,et al. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity , 1993, Molecular and cellular biology.
[7] G. Gabbiani,et al. Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles. , 1988, Differentiation; research in biological diversity.
[8] G. Owens,et al. Molecular regulation of smooth muscle cell differentiation. , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[9] P. Libby,et al. Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy , 2001, Nature Medicine.
[10] M. Reidy,et al. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[11] A. Sharrocks,et al. The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1 , 1994, Molecular and cellular biology.
[12] C. Clendenin,et al. Binding of Serum Response Factor to CArG Box Sequences Is Necessary but Not Sufficient to Restrict Gene Expression to Arterial Smooth Muscle Cells* , 2001, The Journal of Biological Chemistry.
[13] Y. Ohkawa,et al. A Triad of Serum Response Factor and the GATA and NK Families Governs the Transcription of Smooth and Cardiac Muscle Genes* , 2002, The Journal of Biological Chemistry.
[14] S. Folta,et al. Molecular Cloning, Characterization, and Promoter Analysis of the Mouse Crp2/SmLim Gene , 1998, The Journal of Biological Chemistry.
[15] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[16] Y. Yazaki,et al. Isolation of the embryonic form of smooth muscle myosin heavy chain (SMemb/NMHC-B) gene and characterization of its 5'-flanking region. , 1997, Biochemical and biophysical research communications.
[17] E. Fisher,et al. Lysophosphatidylcholine Stimulates Monocyte Chemoattractant Protein-1 Gene Expression in Rat Aortic Smooth Muscle Cells , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[18] F. Marumo,et al. Skeletal and smooth muscle alpha-actin mRNA in endomyocardial biopsy samples of dilated cardiomyopathy patients. , 1998, Life sciences.
[19] A. Becker,et al. Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study. , 1996, Heart.
[20] J. Osbourn,et al. Cloning and analysis of the promoter region of the rat SM22 alpha gene. , 1995, The Biochemical journal.
[21] A. Chobanian,et al. Growth factor expression in aorta of normotensive and hypertensive rats. , 1989, The Journal of clinical investigation.
[22] J. Pickering. Regulation of vascular cell behavior by collagen : form is function. , 2001, Circulation research.
[23] C. Basson,et al. Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF‐β1 correlates with reciprocal effects on cell migration+ , 1992 .
[24] J. Badimón,et al. CCR2 Deficiency Decreases Intimal Hyperplasia After Arterial Injury , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[25] Wei-Yu Tang,et al. [Effects of androgen and estrogen on the expressions of basic fibroblast growth factor, transforming growth factor and smoothelin]. , 2002, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.
[26] A. Somlyo,et al. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. , 2003, Physiological reviews.
[27] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.
[28] J. Small,et al. Metavinculin and vinculin from mammalian smooth muscle: Bulk isolation and characterization , 1987, Journal of Muscle Research & Cell Motility.
[29] R. Treisman,et al. Muscle-specific (CArG) and serum-responsive (SRE) promoter elements are functionally interchangeable in Xenopus embryos and mouse fibroblasts. , 1989, Development.
[30] H. Ives,et al. Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. , 1996, Circulation research.
[31] G. Owens,et al. Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. , 2000, Circulation research.
[32] M. Yanagisawa,et al. Primary structure of chicken skeletal muscle and fibroblast alpha-actinins deduced from cDNA sequences. , 1988, European journal of biochemistry.
[33] G. Owens,et al. The Smooth Muscle Myosin Heavy Chain Gene Exhibits Smooth Muscle Subtype-selective Modular Regulation in Vivo * , 2001, The Journal of Biological Chemistry.
[34] G. Owens,et al. Recruitment of Serum Response Factor and Hyperacetylation of Histones at Smooth Muscle–Specific Regulatory Regions During Differentiation of a Novel P19-Derived In Vitro Smooth Muscle Differentiation System , 2001, Circulation research.
[35] G. Owens,et al. Smooth Muscle Differentiation Marker Gene Expression Is Regulated by RhoA-mediated Actin Polymerization* , 2001, The Journal of Biological Chemistry.
[36] Qingbo Xu,et al. Smooth Muscle Cells in Transplant Atherosclerotic Lesions Are Originated From Recipients, but Not Bone Marrow Progenitor Cells , 2002, Circulation.
[37] J. Miano,et al. Serum response factor: toggling between disparate programs of gene expression. , 2003, Journal of molecular and cellular cardiology.
[38] Y. Yazaki,et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. , 1993, Circulation research.
[39] Helen M. Blau,et al. Biological Progression from Adult Bone Marrow to Mononucleate Muscle Stem Cell to Multinucleate Muscle Fiber in Response to Injury , 2002, Cell.
[40] R. Virmani,et al. Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] G. V. van Eys,et al. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells , 1996, The Journal of cell biology.
[42] G. Owens,et al. Platelet‐derived growth factor regulates actin isoform expression and growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells , 1990, Journal of cellular physiology.
[43] Philippe Soriano. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. , 1997, Development.
[44] G. Gabbiani,et al. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[45] M. Reidy,et al. Mechanisms of stenosis after arterial injury. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[46] C. Jones,et al. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. , 1994, Circulation research.
[47] S M Schwartz,et al. Developmental mechanisms underlying pathology of arteries. , 1990, Physiological reviews.
[48] J. McConville,et al. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. , 2003, American journal of respiratory cell and molecular biology.
[49] G. Gabbiani,et al. Expression of alpha-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes. , 1991, International journal of cancer.
[50] J. Vandekerckhove,et al. Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[51] C. Murre,et al. Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms , 2000, Molecular and Cellular Biology.
[52] L. Heasley,et al. Gα16 Mimics Vasoconstrictor Action to Induce Smooth Muscle α-Actin in Vascular Smooth Muscle Cells through a Jun-NH2-terminal Kinase-dependent Pathway* , 1997, The Journal of Biological Chemistry.
[53] M. Majesky. Decisions, decisions...SRF coactivators and smooth muscle myogenesis. , 2003, Circulation research.
[54] R. Schwartz,et al. Transforming Growth Factor- (cid:1) Induction of Smooth Muscle Cell Phenotpye Requires Transcriptional and Post-transcriptional Control of Serum Response Factor* , 2022 .
[55] B R Johansson,et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.
[56] G. Owens,et al. Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.
[57] D. Metzger,et al. Temporally controlled somatic mutagenesis in smooth muscle , 2000, Genesis.
[58] Da-Zhi Wang,et al. Potentiation of serum response factor activity by a family of myocardin-related transcription factors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[59] L. Kedes,et al. Muscle-specific gene expression. A comparison of cardiac and skeletal muscle transcription strategies. , 1993, Circulation research.
[60] M. Reidy,et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.
[61] K. Ligon,et al. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. , 1994, Circulation research.
[62] O. Kocher,et al. Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. , 1986, Human pathology.
[63] G. Vassilopoulos,et al. Transplanted bone marrow regenerates liver by cell fusion , 2003, Nature.
[64] G. Owens,et al. Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells. , 1989, The Journal of biological chemistry.
[65] L. Khachigian,et al. Zinc Finger Transcription Factors Mediate High Constitutive Platelet-derived Growth Factor-B Expression in Smooth Muscle Cells Derived from Aortae of Newborn Rats* , 1998, The Journal of Biological Chemistry.
[66] R. Nagai,et al. Diverse Contribution of Bone Marrow Cells to Neointimal Hyperplasia After Mechanical Vascular Injuries , 2003, Circulation research.
[67] E. Olson,et al. Restricted expression of homeobox genes distinguishes fetal from adult human smooth muscle cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[68] Wei Zhou,et al. Dominant Negative Murine Serum Response Factor: Alternative Splicing within the Activation Domain Inhibits Transactivation of Serum Response Factor Binding Targets , 1999, Molecular and Cellular Biology.
[69] A. Porteu,et al. An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells. , 2000, Developmental biology.
[70] D. Paulin,et al. Expression of desmin gene in skeletal and smooth muscle by in situ hybridization using a human desmin gene probe. , 1990, Journal of submicroscopic cytology and pathology.
[71] M. Reidy,et al. Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[72] R. Ross,et al. The pathogenesis of atherosclerosis (second of two parts). , 1976, The New England journal of medicine.
[73] W. Edwards,et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[74] J. Thyberg,et al. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently , 1994, Cell and Tissue Research.
[75] T. Haystead,et al. Acceleration of Myosin Light Chain Dephosphorylation and Relaxation of Smooth Muscle by Telokin , 1998, The Journal of Biological Chemistry.
[76] R. Buttyan,et al. Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: A direct comparison , 2000, Neurourology and urodynamics.
[77] Philippe Soriano,et al. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. , 1994, Genes & development.
[78] E. Olson,et al. Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells , 1996, The Journal of cell biology.
[79] A. Hamsten,et al. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. , 2002, The American journal of pathology.
[80] G. Owens,et al. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells , 1988, The Journal of cell biology.
[81] E. Schiffrin,et al. Vascular remodeling. , 1996, Hypertension.
[82] D. Srivastava,et al. The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. , 2000, The Journal of clinical investigation.
[83] E. Olson,et al. Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth, skeletal, and cardiac muscle cells. , 1997, Developmental biology.
[84] E. Olson,et al. Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox. , 1997, Circulation research.
[85] H. Hess. [Significance of blood platelets and coagulation for development, progression and regression of arteriosclerosis]. , 1987, VASA. Supplementum.
[86] M. Ferguson,et al. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. , 1993, Circulation research.
[87] S. Coughlin,et al. A Role for Thrombin Receptor Signaling in Endothelial Cells During Embryonic Development , 2001, Science.
[88] C. T. Kuo,et al. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. , 1997, Genes & development.
[89] J. Sellers,et al. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. , 1991, The Journal of biological chemistry.
[90] T. Allen,et al. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. , 1992, Journal of cell science.
[91] M. Frid,et al. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. , 1994, Circulation research.
[92] M. Periasamy,et al. Characterization of a mammalian smooth muscle myosin heavy-chain gene: complete nucleotide and protein coding sequence and analysis of the 5' end of the gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[93] A. Becker,et al. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. , 1996, The American journal of pathology.
[94] C. Little,et al. Morphogenesis of the First Blood Vessels , 1998, Annals of the New York Academy of Sciences.
[95] J. Black,et al. Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer , 2001, Journal of cellular physiology.
[96] A. Chiavegato,et al. Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant , 2001, Circulation research.
[97] R R Markwald,et al. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. , 1997, Circulation research.
[98] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[99] M. Frid,et al. Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial-Mesenchymal Transdifferentiation: In Vitro Analysis , 2002, Circulation research.
[100] M. Sturek,et al. Functional Nucleotide Receptor Expression and Sarcoplasmic Reticulum Morphology in Dedifferentiated Porcine Coronary Smooth Muscle Cells , 2001, Journal of Vascular Research.
[101] G. Owens,et al. Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. , 1996, Developmental biology.
[102] Da-Zhi Wang,et al. The serum response factor coactivator myocardin is required for vascular smooth muscle development , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[103] K. Sobue,et al. Transcriptional Regulation of the Chicken Caldesmon Gene , 1995, The Journal of Biological Chemistry.
[104] S. Schwartz,et al. Expression Profiling Identifies 147 Genes Contributing to a Unique Primate Neointimal Smooth Muscle Cell Phenotype , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[105] M. Lu,et al. Analysis of SM22α-Deficient Mice Reveals Unanticipated Insights into Smooth Muscle Cell Differentiation and Function , 2001, Molecular and Cellular Biology.
[106] G. Owens,et al. Development of a Smooth Muscle–Targeted Cre Recombinase Mouse Reveals Novel Insights Regarding Smooth Muscle Myosin Heavy Chain Promoter Regulation , 2000, Circulation research.
[107] Rakesh K Jain,et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. , 2002, The American journal of pathology.
[108] G. Owens,et al. Nuclear proteins bind a cis-acting element in the smooth muscle alpha-actin promoter. , 1995, The American journal of physiology.
[109] M. Lu,et al. Myocardin Is a Critical Serum Response Factor Cofactor in the Transcriptional Program Regulating Smooth Muscle Cell Differentiation , 2003, Molecular and Cellular Biology.
[110] B. Weinstein,et al. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. , 2001, Developmental biology.
[111] A. Chiavegato,et al. Myosin isoform expression in smooth muscle cells during physiological and pathological vascular remodeling. , 1994, Journal of vascular research.
[112] M. Sturek,et al. Atorvastatin Treatment Prevents Alterations in Coronary Smooth Muscle Nuclear Ca2+ Signaling in Diabetic Dyslipidemia , 2002, Journal of Vascular Research.
[113] G. Gabbiani,et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation , 1986, The Journal of cell biology.
[114] M. Makuuchi,et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.
[115] Z. Galis,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[116] C. Betsholtz,et al. Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. , 2002, The American journal of pathology.
[117] S. Schwartz,et al. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. , 1992, The Journal of clinical investigation.
[118] Gary R. Grotendorst,et al. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 , 1991, The Journal of cell biology.
[119] M. Deschaseaux,et al. Vascular smooth muscle differentiation of murine stroma: a sequential model. , 1999, Experimental hematology.
[120] S. Nishikawa,et al. Functional Blockade of Platelet-Derived Growth Factor Receptor-&bgr; but Not of Receptor-&agr; Prevents Vascular Smooth Muscle Cell Accumulation in Fibrous Cap Lesions in Apolipoprotein E–Deficient Mice , 2001, Circulation.
[121] E. Schiffrin,et al. Structure and Mechanical Properties of Resistance Arteries in Hypertension: Role of Adhesion Molecules and Extracellular Matrix Determinants , 2000, Hypertension.
[122] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[123] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[124] S. Schwartz,et al. Production of transforming growth factor beta 1 during repair of arterial injury. , 1991, The Journal of clinical investigation.
[125] G. Owens,et al. Expression of the Smooth Muscle Myosin Heavy Chain Gene Is Regulated by a Negative-acting GC-rich Element Located between Two Positive-acting Serum Response Factor-binding Elements* , 1997, The Journal of Biological Chemistry.
[126] G. V. van Eys,et al. Structure and chromosome location of Smtn, the mouse smoothelin gene , 2000, Cytogenetic and Genome Research.
[127] G. Owens,et al. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. , 2000, The Journal of clinical investigation.
[128] S. Schwartz,et al. Cell proliferation in human coronary arteries. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[129] J. Thyberg,et al. Phenotype modulation in primary cultures of arterial smooth-muscle cells. Dual effect of prostaglandin E1. , 1984, Differentiation; research in biological diversity.
[130] N. Voelkel,et al. Microsatellite Instability of Endothelial Cell Growth and Apoptosis Genes Within Plexiform Lesions in Primary Pulmonary Hypertension , 2001, Circulation research.
[131] E. Fuchs,et al. Physiological Control of Smooth Muscle-specific Gene Expression through Regulated Nuclear Translocation of Serum Response Factor* , 2000, The Journal of Biological Chemistry.
[132] A. Grace,et al. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis , 1995, Nature Medicine.
[133] Y. Iwamoto,et al. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma , 2002, Virchows Archiv.
[134] S M Schwartz,et al. The intima. Soil for atherosclerosis and restenosis. , 1995, Circulation research.
[135] J. Small,et al. Calponin and SM 22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. , 1993, Differentiation; research in biological diversity.
[136] J. Fischer,et al. Cultured Arterial Smooth Muscle Cells Maintain Distinct Phenotypes When Implanted Into Carotid Artery , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[137] C. Deng,et al. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. , 1999, Development.
[138] K. Sobue,et al. Transcriptional activation of beta-tropomyosin mediated by serum response factor and a novel Barx homologue, Barx1b, in smooth muscle cells. , 2001, The Journal of biological chemistry.
[139] T. Yokoyama,et al. Homeobox Protein Hex Induces SMemb/Nonmuscle Myosin Heavy Chain-B Gene Expression Through the cAMP-Responsive Element , 2001, Circulation research.
[140] Da-Zhi Wang,et al. Activation of Cardiac Gene Expression by Myocardin, a Transcriptional Cofactor for Serum Response Factor , 2001, Cell.
[141] D. Dichek,et al. Cardiovascular overexpression of transforming growth factor-beta(1) causes abnormal yolk sac vasculogenesis and early embryonic death. , 2000, Circulation research.
[142] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[143] R. Nemenoff,et al. Induction of Smooth Muscle α-Actin in Vascular Smooth Muscle Cells by Arginine Vasopressin Is Mediated by c-Jun Amino-terminal Kinases and p38 Mitogen-activated Protein Kinase* , 2000, The Journal of Biological Chemistry.
[144] A. Geinoz,et al. Heterogeneity of Smooth Muscle Cell Populations Cultured From Pig Coronary Artery , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[145] J. Manak,et al. Phosphorylation of serum response factor by casein kinase II: evidence against a role in growth factor regulation of fos expression. , 1993, Oncogene.
[146] R. A. Murphy,et al. Actin and tropomyosin variants in smooth muscles. Dependence on tissue type. , 1984, The Journal of biological chemistry.
[147] L. Khachigian,et al. Sp1 phosphorylation regulates inducible expression of platelet-derived growth factor B-chain gene via atypical protein kinase C-zeta. , 2001, Nucleic acids research.
[148] C. Little,et al. Developmental Biology of the Vascular Smooth Muscle Cell: Building a Multilayered Vessel Wall , 1999, Journal of Vascular Research.
[149] E. Olson,et al. Expression of the Smooth Muscle Cell Calponin Gene Marks the Early Cardiac and Smooth Muscle Cell Lineages during Mouse Embryogenesis (*) , 1996, The Journal of Biological Chemistry.
[150] G. Owens,et al. Substitution of the Degenerate Smooth Muscle (SM) α-Actin CC(A/T-rich)6GG Elements with c-fos Serum Response Elements Results in Increased Basal Expression but Relaxed SM Cell Specificity and Reduced Angiotensin II Inducibility* , 1998, The Journal of Biological Chemistry.
[151] G. Owens,et al. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence. , 1998, Circulation research.
[152] A. Hoggatt,et al. Identification of Barx2B, a Serum Response Factor-associated Homeodomain Protein* , 2001, The Journal of Biological Chemistry.
[153] M. Hussain,et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion , 2003 .
[154] J. Wilcox. Analysis of local gene expression in human atherosclerotic plaques. , 1992, Journal of vascular surgery.
[155] R. V. Sharma,et al. Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. , 2001, American journal of physiology. Heart and circulatory physiology.
[156] C. Heldin,et al. Platelet-derived growth factor. Three isoforms that bind to two distinct cell surface receptors. , 1989, Acta oncologica.
[157] E. Olson,et al. Muscle Specificity Encoded by Specific Serum Response Factor-binding Sites* , 2001, The Journal of Biological Chemistry.
[158] B. Geiger,et al. Vinculin, an intracellular protein localized at specialized sites where microfilament bundles terminate at cell membranes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[159] V. Koteliansky,et al. Myosin heavy-chain isoform composition and distribution in developing and adult human aortic smooth muscle. , 1993, Journal of vascular research.
[160] Jeffrey W. Streb,et al. Myocardin: a component of a molecular switch for smooth muscle differentiation. , 2002, Journal of molecular and cellular cardiology.
[161] E. Ehler,et al. Human foetal lung (IMR-90) cells: myofibroblasts with smooth muscle-like contractile properties. , 1996, Cell motility and the cytoskeleton.
[162] C. Chaponnier,et al. Vascular smooth muscle cells differ from other smooth muscle cells: Predominance of vimentin filaments and a specific a-type actin , 2003 .
[163] C. Clendenin,et al. A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages , 1997, Molecular and cellular biology.
[164] M. Hori,et al. Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice. , 2002, Atherosclerosis.
[165] H. Uchi,et al. The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-alpha-induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway. , 2002, The Journal of allergy and clinical immunology.
[166] T. Haystead,et al. Endothelial cell-conditioned medium downregulates smooth muscle contractile protein expression. , 1997, The American journal of physiology.
[167] Yan Liu,et al. A Transforming Growth Factor-β Control Element Required for SM α-Actin Expression in Vivo Also Partially Mediates GKLF-dependent Transcriptional Repression* , 2003, Journal of Biological Chemistry.
[168] L. Hansson. The optimal blood pressure reduction , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[169] Masafumi Watanabe,et al. Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2alpha and Mrf2beta. , 2002, Circulation research.
[170] R. Adelstein,et al. Neuronal Cell Expression of Inserted Isoforms of Vertebrate Nonmuscle Myosin Heavy Chain II-B (*) , 1995, The Journal of Biological Chemistry.
[171] E. Turley. Extracellular matrix remodeling: multiple paradigms in vascular disease. , 2001, Circulation research.
[172] S. Sartore,et al. Nonmuscle and smooth muscle myosin isoforms in bovine endothelial cells. , 1990, Experimental cell research.
[173] P. Gallagher,et al. Telokin expression is restricted to smooth muscle tissues during mouse development. , 2001, American journal of physiology. Cell physiology.
[174] E. Popa,et al. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. , 2001, The Journal of clinical investigation.
[175] A. Cho,et al. Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[176] David Welch,et al. Decisions, Decisions , 2001 .
[177] R J Schwartz,et al. Organization and Myogenic Restricted Expression of the Murine Serum Response Factor Gene , 1997, The Journal of Biological Chemistry.
[178] C. Little,et al. Avian vasculogenesis and the distribution of collagens I, IV, laminin, and fibronectin in the heart primordia. , 1990, The Journal of experimental zoology.
[179] David J. Anderson,et al. Alternative Neural Crest Cell Fates Are Instructively Promoted by TGFβ Superfamily Members , 1996, Cell.
[180] G. Owens,et al. A Transforming Growth Factor β (TGFβ) Control Element Drives TGFβ-induced Stimulation of Smooth Muscle α-Actin Gene Expression in Concert with Two CArG Elements* , 1997, The Journal of Biological Chemistry.
[181] C. Heldin,et al. Signal transduction via platelet-derived growth factor receptors. , 1998, Biochimica et biophysica acta.
[182] R. Ross,et al. PLATELET-DERIVED GROWTH FACTOR , 1989, The Lancet.
[183] R. Schwartz,et al. A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. , 1999, Development.
[184] G. Gabbiani,et al. α-Smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles , 1988 .
[185] R. Schwartz,et al. The Smooth Muscle γ-Actin Gene Promoter Is a Molecular Target for the Mouse bagpipe Homologue, mNkx3-1, and Serum Response Factor* , 2000, The Journal of Biological Chemistry.
[186] C. Heldin,et al. Platelet-derived growth factor: mechanism of action and possible in vivo function. , 1990, Cell regulation.
[187] M. Davies,et al. Effect of Platelet-Derived Growth Factor Receptor-α and -β Blockade on Flow-Induced Neointimal Formation in Endothelialized Baboon Vascular Grafts , 2000 .
[188] A. Czirók,et al. Multi‐field 3D scanning light microscopy of early embryogenesis , 2002, Journal of microscopy.
[189] M. Daemen,et al. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[190] J. Campbell,et al. Smooth muscle phenotypic expression in human carotid arteries. II. Atherosclerosis-free diffuse intimal thickenings compared with the media. , 1986, Arteriosclerosis.
[191] J. Metcalfe,et al. Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity. , 2000, The Biochemical journal.
[192] Christopher P. Regan,et al. Positive- and Negative-acting Krüppel-like Transcription Factors Bind a Transforming Growth Factor β Control Element Required for Expression of the Smooth Muscle Cell Differentiation Marker SM22α in Vivo * , 2000, The Journal of Biological Chemistry.
[193] J. P. Hobson,et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.
[194] G. Owens,et al. Differential activation of the SMαA promoter in smooth vs. skeletal muscle cells by bHLH factors. , 1999, American journal of physiology. Cell physiology.
[195] R. Ross,et al. The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.
[196] Jean Paul Thiery,et al. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[197] K. Hirschi,et al. PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.
[198] R. V. Sharma,et al. Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells. , 2001, Journal of applied physiology.
[199] J. Miano,et al. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. A putative in vivo mechanism for autocrine growth. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[200] P. Qiu,et al. Histone Acetylation and Recruitment of Serum Responsive Factor and CREB-Binding Protein Onto SM22 Promoter During SM22 Gene Expression , 2002, Circulation research.
[201] NobuyukiKomiyama,et al. Redifferentiation of Smooth Muscle Cells After Coronary Angioplasty Determined via Myosin Heavy Chain Expression , 1997 .
[202] D. Stemple,et al. In Vitro System for Differentiating Pluripotent Neural Crest Cells into Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.
[203] M. Taketo,et al. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. , 1996, Developmental biology.
[204] S. Schwartz,et al. The aortic intima. II. Repair of the aortic lining after mechanical denudation. , 1975, The American journal of pathology.
[205] O. Kocher,et al. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[206] C. Betsholtz,et al. PDGF-A Signaling Is a Critical Event in Lung Alveolar Myofibroblast Development and Alveogenesis , 1996, Cell.
[207] W. Baumgartner,et al. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. , 1993, The American journal of pathology.
[208] J. Miano,et al. Serum Response Factor-dependent Regulation of the Smooth Muscle Calponin Gene* , 2000, The Journal of Biological Chemistry.
[209] J. Small,et al. Mammalian calponin , 1993, FEBS letters.
[210] M. Hussain,et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. , 2003, The Journal of clinical investigation.
[211] C. Hsieh,et al. Characterization of the Mouse Aortic Carboxypeptidase-Like Protein Promoter Reveals Activity in Differentiated and Dedifferentiated Vascular Smooth Muscle Cells , 2002, Circulation research.
[212] C. Hsieh,et al. APEG-1, a Novel Gene Preferentially Expressed in Aortic Smooth Muscle Cells, Is Down-regulated by Vascular Injury* , 1996, The Journal of Biological Chemistry.
[213] B. Folkow. Physiological aspects of primary hypertension. , 1982, Physiological reviews.
[214] R. Treisman. Ternary complex factors: growth factor regulated transcriptional activators. , 1994, Current opinion in genetics & development.
[215] A. Harel-Bellan,et al. Physical Interaction between the Mitogen-responsive Serum Response Factor and Myogenic Basic-Helix-Loop-Helix Proteins (*) , 1996, The Journal of Biological Chemistry.
[216] G. Owens,et al. Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. , 1986, The Journal of biological chemistry.
[217] G. Owens,et al. Combinatorial Control of Smooth Muscle–Specific Gene Expression , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[218] G. Eichele,et al. Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription. , 1996, Developmental biology.
[219] J. Epstein,et al. Smooth Muscle Cells, But Not Myocytes, of Host Origin in Transplanted Human Hearts , 2002, Circulation.
[220] L. Heasley,et al. Suppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2. , 1997, The Biochemical journal.
[221] T. Hadjistilianou,et al. Expression of actin isoforms and intermediate filament proteins in childhood orbital rhabdomyosarcomas. , 1989, Journal of submicroscopic cytology and pathology.
[222] M. Peach,et al. Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. , 1992, Circulation research.
[223] Da-Zhi Wang,et al. Myocardin is a master regulator of smooth muscle gene expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[224] B Swolin,et al. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. , 1994, Genes & development.
[225] R. A. Murphy,et al. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. , 1986, The Journal of biological chemistry.
[226] Y. Yazaki,et al. Transcription factor PU.1 mediates induction of c-fms in vascular smooth muscle cells: a mechanism for phenotypic change to phagocytic cells , 1996, Molecular and cellular biology.
[227] W. M. Lee,et al. Alterations in population dynamics of arterial smooth muscle cells during atherogenesis. IV. Evidence for a polyclonal origin of hypercholesterolemic diet-induced atherosclerotic lesions in young swine. , 1976, Experimental and molecular pathology.
[228] M. Grompe,et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes , 2003, Nature.
[229] K. Hermsmeyer. Calcium channel function in hypertension. , 1993, Journal of human hypertension.
[230] P. Anversa,et al. Chimerism of the transplanted heart. , 2002, The New England journal of medicine.
[231] E. Olson,et al. Modular regulation of muscle gene transcription: a mechanism for muscle cell diversity. , 1997, Trends in genetics : TIG.
[232] V. Koteliansky,et al. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. , 1992, Developmental biology.
[233] C L Seidel,et al. Migratory abilities of different vascular cells from the tunica media of canine vessels. , 1997, The American journal of physiology.
[234] S. Schwartz,et al. Replication of smooth muscle cells in vascular disease. , 1986, Circulation research.
[235] R. Treisman,et al. Actin Dynamics Control SRF Activity by Regulation of Its Coactivator MAL , 2003, Cell.
[236] M. Sturek,et al. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[237] L. Jonasson,et al. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. , 1986, Clinical and experimental immunology.
[238] E. Olson,et al. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. , 1996, Circulation research.
[239] M. Reidy,et al. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[240] P. Libby,et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[241] O. Ornatsky,et al. Diversity of vinculin/meta-vinculin in human tissues and cultivated cells. Expression of muscle specific variants of vinculin in human aorta smooth muscle cells. , 1988, The Journal of biological chemistry.
[242] K. Sobue,et al. Transcriptional Activation of β-Tropomyosin Mediated by Serum Response Factor and a Novel Barx Homologue, Barx1b, in Smooth Muscle Cells* , 2001, The Journal of Biological Chemistry.
[243] A. Kulkarni,et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.
[244] E. Morrisey,et al. Developmental Pattern of Expression and Genomic Organization of the Calponin-h1 Gene , 1996, The Journal of Biological Chemistry.
[245] T. McCaffrey,et al. Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. , 1997, The Journal of clinical investigation.
[246] T. Quertermous,et al. Cloning of capsulin, a basic helix-loop-helix factor expressed in progenitor cells of the pericardium and the coronary arteries 1 The sequence reported in this paper has been deposited in the Genbank data base (accession no.: AF029753) 1 , 1998, Mechanisms of Development.
[247] A. Gown,et al. Immunohistochemical Distinction of Invasive From Noninvasive Breast Lesions: A Comparative Study of p63 Versus Calponin and Smooth Muscle Myosin Heavy Chain , 2003, The American journal of surgical pathology.
[248] Da-Zhi Wang,et al. Myocardin Is a Key Regulator of CArG-Dependent Transcription of Multiple Smooth Muscle Marker Genes , 2003, Circulation research.
[249] J. Osbourn,et al. Cloning and analysis of the promoter region of the rat SM22α gene , 1995 .
[250] Z. Galis,et al. Targeted Disruption of the Matrix Metalloproteinase-9 Gene Impairs Smooth Muscle Cell Migration and Geometrical Arterial Remodeling , 2002, Circulation research.
[251] R. Panettieri. Airway smooth muscle: an immunomodulatory cell. , 2002, The Journal of allergy and clinical immunology.
[252] Julie H. Campbell,et al. Circulating Bone Marrow Cells Can Contribute to Neointimal Formation , 2001, Journal of Vascular Research.
[253] S. Nam,et al. Alterations in population dynamics of arterial smooth muscle cells during atherogenesis. I. Activation of interphase cells in cholesterol-fed swine prior to gross atherosclerosis demonstrated by "postpulse-salvage labeling". , 1971, Experimental and molecular pathology.
[254] B. Wamhoff,et al. Coronary smooth muscle adaptation to exercise: does it play a role in cardioprotection? , 2003, Acta physiologica Scandinavica.
[255] J. D’Armiento,et al. Increased Medial Degradation With Pseudo-Aneurysm Formation in Apolipoprotein E–Knockout Mice Deficient in Tissue Inhibitor of Metalloproteinases-1 , 2003, Circulation.
[256] K. Walsh,et al. Control of vascular cell differentiation by homeiobox transcription factors. , 2001, Circulation research.
[257] W. Lederer,et al. Membrane depolarization, elevated Ca(2+) entry, and gene expression in cerebral arteries of hypertensive rats. , 2001, American journal of physiology. Heart and circulatory physiology.
[258] J. Thyberg,et al. A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. , 1989, Developmental biology.
[259] A. Cho,et al. Matrix Metalloproteinase-9 Is Necessary for the Regulation of Smooth Muscle Cell Replication and Migration After Arterial Injury , 2002, Circulation research.
[260] N. Caplice,et al. Smooth Muscle Progenitor Cells in Human Blood , 2002, Circulation.
[261] G. Owens,et al. The Smooth Muscle α-Actin Gene Promoter Is Differentially Regulated in Smooth Muscle versus Non-smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.
[262] H. Augustin,et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.
[263] R. Sternglanz,et al. Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system , 1995, Molecular and cellular biology.
[264] B. Herring,et al. Telokin expression is mediated by a smooth muscle cell-specific promoter. , 1996, The American journal of physiology.
[265] L. Heasley,et al. Galpha16 mimics vasoconstrictor action to induce smooth muscle alpha-actin in vascular smooth muscle cells through a Jun-NH2-terminal kinase-dependent pathway. , 1997, The Journal of biological chemistry.
[266] S. Schwartz,et al. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[267] G. Owens,et al. Interaction of CArG Elements and a GC-rich Repressor Element in Transcriptional Regulation of the Smooth Muscle Myosin Heavy Chain Gene in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.
[268] N. Chegini,et al. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1. , 1999, Molecular human reproduction.
[269] A. Hoggatt,et al. Cell-Specific Regulatory Modules Control Expression of Genes in Vascular and Visceral Smooth Muscle Tissues , 2002, Circulation research.
[270] P. Libby,et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. , 1998, Circulation research.
[271] C. Allis,et al. Histone methylation versus histone acetylation: new insights into epigenetic regulation. , 2001, Current opinion in cell biology.
[272] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[273] Y. Yazaki,et al. BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. , 1999, Circulation research.
[274] G. Owens,et al. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. , 2001, The Journal of clinical investigation.
[275] N. Williams,et al. Smooth muscle cholinergic denervation hypersensitivity in diverticular disease , 2003, The Lancet.
[276] R. Nemenoff,et al. Hypoxia-induced pulmonary vascular remodeling: contribution of the adventitial fibroblasts. , 2000, Physiological research.
[277] P. Libby,et al. Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. , 1998, Circulation research.
[278] D. Carey,et al. Control of growth and differentiation of vascular cells by extracellular matrix proteins. , 1991, Annual review of physiology.
[279] J. Thyberg,et al. Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. , 1983, Differentiation; research in biological diversity.
[280] G. Owens,et al. Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. , 1999, Circulation research.
[281] J. Peltonen,et al. Extracellular matrix gene expression by human endothelial and smooth muscle cells. , 1991, Matrix.
[282] S. White,et al. Identification of Promoter Elements Involved in Cell-specific Regulation of Rat Smooth Muscle Myosin Heavy Chain Gene Transcription* , 1996, The Journal of Biological Chemistry.
[283] A. Tedgui,et al. Inhibition of Transforming Growth Factor- Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice , 2001 .
[284] G. Gabbiani,et al. Expression of α‐sooth‐muscle actin in stromal cells of the uterine cervix during epithlial neoplastic changes , 1991 .
[285] G. Burnstock,et al. Dedifferentiation, redifferentiation and bundle formation of smooth muscle cells in tissue culture: the influence of cell number and nerve fibres. , 1974, Journal of embryology and experimental morphology.
[286] S. Flavahan,et al. Redox Regulation of Vascular Smooth Muscle Cell Differentiation , 2001, Circulation research.
[287] K. Hirschi,et al. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. , 1999, Circulation research.
[288] K. Walsh,et al. Control of vascular cell differentiation by homeobox transcription factors. , 2003, Trends in cardiovascular medicine.
[289] P. Donahoe,et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[290] R. Ross,et al. The smooth muscle cell in culture. , 1979, Physiological reviews.